Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Franklin Cockerill, Stephen Suffin, Arthur Levinson


Quest Diagnostics announced that Franklin Cockerill, III, is its new VP and chief laboratory officer as of Oct. 1. Cockerill was most recently CEO of Mayo Medical Laboratories and served as the chair of laboratory medicine and pathology for the Mayo Clinic. He has held several leadership positions, including chairing the Microbiology Devices Panel of the US Food and Drug Administration’s Medical Devices Advisory Committee; serving as an editor of the Journal of Clinical Microbiology; and serving as a program chair and board member of the Association for Molecular Pathology.

At Quest, Cockerill will oversee Quest’s lab network and lead the firm’s medical affairs strategies, and academic and government collaborations. He will replace Stephen Suffin, who is retiring at the end of the year but will continue to consult through 2015.

Roche announced that Arthur Levinson has resigned from its board of directors, effective immediately. The drugmaker said Levinson, who was chairman and CEO at Genentech from 1999 to 2014, made the decision to avoid any conflict with his post as CEO at Calico, a Google-backed startup. Levinson has served on Roche's board since 2010.